Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 12 of 12 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Clear Filters
A Pharmacokinetic and Safety study comparing Fluticasone Propionate and Albuterol Sulfate to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
- Condition(s):
- Respiratory
- Status:
- Recruiting
- Requirements:
- 4 Years to 11 Years
- Interventions:
- Drug: TEV-56248
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy Safety and Efficacy Study (TOPAS-MSA)
- Condition(s):
- Multiple System Atrophy
- Status:
- Recruiting
- Requirements:
- 30 Years and older
- Interventions:
- Drug: TEV-56286 (emrusolmin, anle138b)
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
- Condition(s):
- Vitiligo
- Status:
- Recruiting
- Requirements:
- 18 Years to 75 Years
- Interventions:
- Drug: TEV-53408
Fixed-Dose Fluticasone Propionate/Albuterol Sulfate in Preventing Asthma Exacerbations
- Condition(s):
- Asthma
- Status:
- Recruiting
- Requirements:
- 4 years and older
- Interventions:
- Drug: TEV-56248 | Drug: Albuterol sulfate
Long-Term Effect of TEV-48574 in Ulcerative Colitis or Crohn's Disease
- Condition(s):
- Crohn's Disease Colitis, Ulcerative
- Status:
- Recruiting
- Requirements:
- Adult
- Interventions:
- Drug: TEV-48574
Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
- Condition(s):
- Schizophrenia
- Status:
- Recruiting
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TV-44749
Pharmacokinetic Study of TV-44749 Extended-release in Participants with Schizophrenia
- Condition(s):
- Schizophrenia, Schizoaffective Disorder
- Status:
- Recruiting
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TV-44749
Safety and Activity of TEV-56278, as a Monotherapy and in Combination with Pembrolizumab in Participants with Selected Locally Advanced or Metastatic Solid Tumors
- Condition(s):
- Advanced Solid Tumors
- Status:
- Recruiting
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TEV-56278
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
- Condition(s):
- Schizophrenia
- Status:
- Recruiting
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TV-44749
Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years
- Condition(s):
- Migraine
- Status:
- Recruiting
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
- Condition(s):
- Migraine
- Status:
- Recruiting
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab
Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Condition(s):
- Crohn's Disease
- Status:
- Recruiting
- Requirements:
- Adult
- Interventions:
- Drug: TEV-48574 | Drug: Placebo
